← Back to headlines
VERAXA Biotech Secures $27.5M Financing and Plans SPAC Merger
VERAXA Biotech has announced it secured $27.5 million in financing and intends to go public through a SPAC merger.
28 May, 16:53 — 28 May, 16:53
Sources
Showing 1 of 1 sources
